Marvell Technology’s Whiplash: Analyst Upgrades Collide With Insider Sales and a 40% Stock Shed

Marvell Technology’s stock rebounded 4.63% to €172.76 on Monday, recouping some of the ground lost in a sell-off that had dragged the shares more than 40% below their 52-week high of €290.35. The bounce came as several Wall Street firms raised price targets in the wake of the chipmaker’s acquisition of XConn Technologies — a deal that closed on February 10, 2026, and has elevated chiplet connectivity to a central piece of Marvell’s data-center strategy. KeyBanc lifted its target to $400, after an earlier increase to $385, while Bank of America, Stifel, and UBS set new marks of $365, $350, and $340, respectively, citing the launch of the Teralynx T-100 chip.

Yet the rally masks a deeper fracture in investor sentiment. The stock lost roughly 13.3% in the prior week alone, driven by mounting valuation concerns that have overshadowed a string of strong operational numbers. Marvell’s fiscal first-quarter revenue hit $2.418 billion, up 27.6% year over year, with the data-center segment contributing $1.833 billion — 76% of the total. Chief executive Matt Murphy guided for second-quarter revenue of around $2.7 billion, a 35% year-on-year increase, and said the company had “materially” raised its revenue forecasts for fiscal 2027 and 2028.

The disconnect between fundamentals and share price crystallized on July 14, when Erste Group analyst Hans Engel downgraded Marvell from Buy to Hold. Engel argued that heavy reliance on a small number of large customers makes Marvell’s margins vulnerable over the long haul. The stock slid 7.3% that same day, and further losses followed — another 5% on Thursday, as sector-wide profit-taking in semiconductors and AI names spilled over. Even a record second quarter from TSMC, which raised its investment outlook, failed to stem the tide; the Taiwanese giant warned of higher prices, rippling through the chip sector.

Valuation remains the central fault line. Marvell trades at a non-GAAP price-to-earnings ratio of 70 to 80, far above the sector average of 20 to 25. The Erste Group pegs the specific P/E at 73.56, though it notes a PEG ratio of just 0.13 — suggesting the multiple might be justified by the growth trajectory. The stock’s relative strength index of 35.3 now signals it is nearing oversold territory, historically a potential floor for contrarian buyers.

Should investors sell immediately? Or is it worth buying Marvell Technology?

Insider activity has added to the caution. Over the past three months, Marvell executives sold roughly $27.2 million worth of shares. Chief financial officer Dan Durn offloaded 2,250 shares on June 23 at $281.01, trimming his position by nearly a quarter. The sales stand in contrast to the bullish outlook from Wall Street, where the consensus remains a Strong Buy with an average price target of $270.83, though forecasts range from $155 to $400.

Marvell’s path increasingly invites comparison to Broadcom, its closest rival in custom silicon. Broadcom posted second-quarter revenue of $22.19 billion, up 47.9%, with AI semiconductor revenue surging 143% to $10.8 billion. At a market capitalization of $1.78 trillion, Broadcom operates in a different league, but Marvell — valued at roughly €148 billion — is seen as a faster, nimbler pursuer. Seeking Alpha analysts project Marvell’s custom ASIC business could grow from $1.5 billion today to over $4 billion by fiscal 2028.

The next test arrives on August 27, when Marvell reports fiscal second-quarter results. The company has guided for a non-GAAP profit of $0.93 per share, plus or minus five cents, on revenue in a range of $2.7 billion plus or minus 5%. Analysts, on average, expect earnings of $0.87 per share and revenue of $2.70 billion — up from $0.67 and $2.01 billion a year earlier. For a stock that remains 40.5% below its peak and below its 50-day moving average of €209.94, the earnings call will be the ultimate test of whether the growth story can finally catch up with the multiple.